Admission Date:  [**2161-10-18**]              Discharge Date:   [**2161-11-5**]

Date of Birth:  [**2099-7-2**]             Sex:   M

Service: MEDICINE

Allergies:
Patient recorded as having No Known Allergies to Drugs

Attending:[**First Name3 (LF) 3276**]
Chief Complaint:
dyspnea, low grade fever

Major Surgical or Invasive Procedure:
pleurex catheter drainage
EGD


History of Present Illness:
Mr. [**Known lastname 42603**] is a 62 year old male with a h/o metastatic large
cell lung cancer to bone c/b recurrent malignant pleural
effusion requiring pleurex catheter placement, HIV (CD4 535) on
HAART, htn who presented to the ED with pleuritic CP and dyspnea
which has been his long standing issues. He further states that
he flt like he was dying and is not cmofortable with going home.
In ED vitals were stable with sats 100% on 1.5L o2 and bp of
134/89, temp 99.4. labs are at baseline. CXR revealed moderate
to large left sided pleural effusion with pleurex drain and
minimal interval changes. His temp subsequently went to 100.5
although he [**Doctor First Name 1638**] any neck stiffness, photophobia, cough,
nausea, vomiting, diarrhoea, dysuria or rash. He was cultured
and started on vanco and zosyn. He's seen by psych who felt he's
not at suicidal risk. He's admitted for further care.

Past Medical History:
[**7-/2159**]: Diagnosed with non small cell lung cancer by CT guided
biopsy
[**2159-9-20**]: PET scan with low-attenuation lesion in the left
lobe of the thyroid gland measuring 25 x 7 mm in addition to
markedly FDG avid left upper lobe mass consistent with known
cancer and FDG avid prominent bilateral axillary lymphadenopathy
suspicious for metastatic disease, but no pathologically
enlarged
infraclavicular lymph nodes.  He also had retroperitoneal
internal and external iliac chain FDG avid lymphadenopathy
considered unusual for lung carcinoma.
[**2159-10-29**]: FNA of the thyroid, which was negative.
[**2159-10-31**]: Left axillary lymph node dissection.  With pathology
revealing florid reactive follicular hyperplasia consistent with
HIV associated lymphadenopathy.  Further staging and treatment
were deferred until the patient was stabilized on HAART therapy.
 He was
initially seen by infectious disease doctors [**Last Name (NamePattern4) **] [**2160-1-10**] and
was started on HAART therapy in 01/[**2160**].
[**3-/2160**]: He was hospitalized for influenza.  After the
hospitalization, he was lost to follow up until [**Month (only) **].  Other
than the visit with his infectious disease on [**2160-5-5**], he then
lost to follow up until [**7-13**].
[**2160-7-24**]: CT demonstrated left upper lobe mass minimally
increased in size from [**3-/2160**] with a sub 5 mm left upper lobe
pulmonary nodule
with additional stable bilateral nodules, new left-sided pleural
effusion.
[**2160-8-6**]: Bronchoscopy, mediastinoscopy, and pleural drainage
and talc pleurodesis by Dr. [**Last Name (STitle) **].  Pathology revealed 4R lymph
nodes with no malignancy but frozen sections showed metastatic
large cell carcinoma and 4L lymph nodes that showed metastatic
large cell carcinoma.  A level 7 lymph node showed metastatic
large cell carcinoma and a parietal pleural biopsy also showed
metastatic large cell carcinoma involving the pleura. He was
started on carboplatin and
gemcitabine on [**2160-8-28**] he has completed 4 cycles.
[**2160-12-5**]: MR [**Name13 (STitle) **] with L1 lesion
.
MEDICAL HISTORY:
- Peripheral vestibulopathy
- HIV: Diagnosed in the [**2142**], he had been previously
cared for by Dr. [**First Name8 (NamePattern2) 333**] [**Last Name (NamePattern1) 42604**] at [**Hospital6 **].
[**2160-10-30**] -> CD4 425, VL undetectable
- Positive PPD-negative AFB [**1-11**]-s/p 6 months Rifampin in
[**2148**].
- Hypertension.
- History of appendicitis status post appendectomy in [**2126**].


Social History:
He is originally of Haitian origin.  His wife
and children live in [**Country 2045**].  He is an employee in the food
service industry here at [**Hospital1 18**].  He reports a prior history
of tobacco, having stopped in [**2148**].  He is sexually active only
with women.  He denies any intravenous drug use.  He received
transfusions potentially around the time of his appendectomy in
[**2126**].


Family History:
No premature CAD or cancer.

Physical Exam:
T: 97.6 BP: 122/89 HR: 100 RR: 20 O2 100% 2LNC
Gen: Pleasant, chronically ill appearing male in NAD
HEENT: No conjunctival pallor. No icterus. MMM. OP clear.
NECK: Supple. JVP low.
CV: RRR. nl S1, S2. No murmurs, rubs or [**Last Name (un) 549**]
LUNGS: Prominent breath sounds. Decreased on L halfway up.
ABD: NABS. Soft, NT, ND. No HSM
EXT: WWP, NO CCE. Full distal pulses bilaterally.
SKIN: No rashes/lesions, ecchymoses.
NEURO: A&Ox3. Appropriate. CN 2-12 grossly intact. Moving all
extremities.

Exam at discharge:
O:  126/88  99  99.1  98% RA   1154/1520
Gen: Pleasant, chronically ill appearing male in NAD
HEENT: No conjunctival pallor. No icterus. MMM. OP clear.
NECK: Supple. JVP low.
CV: RRR. nl S1, S2. No murmurs, rubs or [**Last Name (un) 549**],  mild chest
discomfort reproducible over sternum
LUNGS: Prominent breath sounds. Decreased on L halfway up.
ABD: NABS. Soft, NT, ND. No HSM
EXT: WWP, NO CCE. Full distal pulses bilaterally.
SKIN: No rashes/lesions, ecchymoses.
NEURO: A&Ox3. Appropriate. CN 2-12 grossly intact. Moving all
extremities.

Pertinent Results:
[**2161-10-18**]  WBC-10.7  Hgb-9.8* Hct-30.9*   Plt Ct-577*
[**2161-10-19**]  WBC-3.6*#  Hgb-8.6* Hct-25.8*   Plt Ct-397
[**2161-10-19**]  WBC-2.3*  Hgb-9.6* Hct-29.3*   Plt Ct-379
[**2161-10-20**]  WBC-1.5*  Hgb-9.0* Hct-27.7*   Plt Ct-319
[**2161-10-21**]  WBC-2.1*  Hgb-9.1* Hct-27.4*   Plt Ct-257
[**2161-10-22**]  WBC-2.9*  Hgb-8.6* Hct-26.6*   Plt Ct-220
[**2161-10-23**]  WBC-3.8*  Hgb-8.9* Hct-27.3*   Plt Ct-169
[**2161-10-24**]  WBC-3.9*  Hgb-8.2* Hct-25.4*   Plt Ct-167
[**2161-10-24**]  WBC-4.0  Hgb-8.5* Hct-26.9*   Plt Ct-153
[**2161-10-25**]  WBC-4.5  Hgb-7.4* Hct-21.9*   Plt Ct-178
[**2161-10-26**]  WBC-5.5  Hgb-7.9* Hct-24.0*   Plt Ct-182
[**2161-10-27**]  WBC-6.4  Hgb-9.2* Hct-26.7*   Plt Ct-172
[**2161-10-28**]  WBC-7.0  Hgb-9.8* Hct-28.6*   Plt Ct-227
[**2161-10-29**]  WBC-8.5  Hgb-9.6* Hct-28.7*   Plt Ct-279
[**2161-10-30**]  WBC-8.3  Hgb-9.4* Hct-29.7*   Plt Ct-359
[**2161-10-31**]  WBC-7.8  Hgb-9.8* Hct-29.6*   Plt Ct-458*
[**2161-11-1**]  WBC-7.9  Hgb-9.3* Hct-28.5*   Plt Ct-521*
[**2161-11-2**]  WBC-5.8  Hgb-9.7* Hct-29.3*   Plt Ct-595*
[**2161-11-4**]  WBC-6.8  Hgb-9.3* Hct-29.4*   Plt Ct-676*
[**2161-11-5**]  WBC-7.5  Hgb-9.0* Hct-28.0*   Plt Ct-656*

[**2161-10-28**]   WBC-7.0 Lymph-43* Abs [**Last Name (un) **]-3010 CD3%-78 Abs CD3-2339*
CD4%-16 Abs CD4-483 CD8%-61 Abs CD8-1824* CD4/CD8-0.3*

[**2161-10-18**]   UreaN-11 Creat-1.2 Na-136 K-4.6 Cl-96 HCO3-28
AnGap-17
[**2161-10-19**]   UreaN-10 Creat-1.1 Na-139 K-3.8 Cl-102 HCO3-30
AnGap-11
[**2161-10-20**]   UreaN-6 Creat-1.2 Na-140 K-3.7 Cl-103 HCO3-30
AnGap-11
[**2161-10-21**]   UreaN-11 Creat-1.4* Na-142 K-3.8 Cl-102 HCO3-31
AnGap-13
[**2161-10-22**]   UreaN-9 Creat-1.4* Na-141 K-3.7 Cl-100 HCO3-31
AnGap-14
[**2161-10-23**]   UreaN-8 Creat-1.6* Na-141 K-4.0 Cl-104 HCO3-30
AnGap-11
[**2161-10-23**]   UreaN-8 Creat-1.6* Na-138 K-3.9 Cl-100 HCO3-29
AnGap-13
[**2161-10-24**]   UreaN-7 Creat-1.7* Na-139 K-3.6 Cl-101 HCO3-30
AnGap-12
[**2161-10-25**]   UreaN-7 Creat-1.7* Na-138 K-4.0 Cl-100 HCO3-30
AnGap-12
[**2161-10-26**]   UreaN-10 Creat-2.0* Na-139 K-4.0 Cl-100 HCO3-31
AnGap-12
[**2161-10-27**]   UreaN-13 Creat-2.0* Na-140 K-4.2 Cl-103 HCO3-29
AnGap-12
[**2161-10-28**]   UreaN-10 Creat-2.0* Na-141 K-4.0 Cl-102 HCO3-30
AnGap-13
[**2161-10-29**]   UreaN-11 Creat-2.1* Na-143 K-4.0 Cl-105 HCO3-26
AnGap-16
[**2161-10-30**]   UreaN-11 Creat-2.3* Na-143 K-4.2 Cl-105 HCO3-29
AnGap-13
[**2161-10-31**]   UreaN-11 Creat-2.3* Na-141 K-4.2 Cl-105 HCO3-28
AnGap-12
[**2161-11-1**]   UreaN-12 Creat-2.3* Na-143 K-4.3 Cl-105 HCO3-30
AnGap-12
[**2161-11-2**]   UreaN-11 Creat-2.3* Na-145 K-4.3 Cl-105 HCO3-29
AnGap-15
[**2161-11-3**]   UreaN-9 Creat-1.9* Na-143 K-4.1 Cl-104 HCO3-29
AnGap-14
[**2161-11-4**]   UreaN-8 Creat-2.1* Na-147* K-4.3 Cl-108 HCO3-31
AnGap-12
[**2161-11-5*